HomeVLA • EPA
add
Valneva SE
Previous close
€3.45
Day range
€3.41 - €3.55
Year range
€2.95 - €7.85
Market cap
491.98M EUR
Avg Volume
576.22K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 41.90M | -79.13% |
Operating expense | 29.44M | 78.88% |
Net income | -32.16M | 27.25% |
Net profit margin | -76.75 | -248.71% |
Earnings per share | -0.47 | -211.55% |
EBITDA | -28.35M | -177.47% |
Effective tax rate | -13.81% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 126.08M | -56.44% |
Total assets | 460.06M | -25.96% |
Total liabilities | 331.82M | -17.37% |
Total equity | 128.25M | — |
Shares outstanding | 138.79M | — |
Price to book | 3.75 | — |
Return on assets | -15.95% | — |
Return on capital | -22.70% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -32.16M | 27.25% |
Cash from operations | -65.91M | -18.06% |
Cash from investing | -16.32M | -148.30% |
Cash from financing | 36.94M | -60.48% |
Net change in cash | -45.17M | -277.21% |
Free cash flow | -45.20M | -18.56% |
About
Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
Founded
2013
Website
Employees
676